Y-Intercept (HK)’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-152,638
Closed -$2.98M – 2035
2026
Q2
$2.98M Buy
+152,638
New +$3.03M 0.06% 480
2025
Q4
– Sell
-321,988
Closed -$6M – 1941
2025
Q3
$6M Buy
+321,988
New +$6.01M 0.14% 158
2025
Q2
– Sell
-49,710
Closed -$868K – 1966
2025
Q1
$868K Buy
+49,710
New +$838K 0.06% 463
2024
Q2
– Sell
-67,562
Closed -$998K – 1856
2024
Q1
$998K Buy
67,562
+37,867
+128% +$524K 0.08% 392
2023
Q4
$424K Buy
+29,695
New +$422K 0.04% 673
2023
Q3
– Sell
-22,095
Closed -$260K – 1525
2023
Q2
$260K Buy
+22,095
New +$252K 0.03% 831
2022
Q2
– Sell
-21,443
Closed -$319K – 1153
2022
Q1
$319K Buy
21,443
+2,704
+14% +$37K 0.07% 426
2021
Q4
$254K Sell
18,739
-15,308
-45% -$217K 0.06% 444
2021
Q3
$501K Buy
+34,047
New +$575K 0.09% 332

Other funds holding SBRA

Y-Intercept (HK)'s SBRA Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Sabra Healthcare REIT (SBRA) in Q3 2026, closing a stake of 152,638 shares — an estimated $2.98M sold.

Y-Intercept (HK) first reported a position in SBRA in Q3 2021 and held it in 9 quarters. The position peaked at $6M in Q3 2025. 87 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Sabra Healthcare REIT position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 152,638 Sabra Healthcare REIT shares in Q3 2026, an estimated $2.98M.
  • Y-Intercept (HK) first reported a position in Sabra Healthcare REIT in Q3 2021 and held it in 9 quarters.
  • Y-Intercept (HK)'s Sabra Healthcare REIT position peaked at $6M in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.